Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

A Pilot Study on Evaluation of Standardized Ayurveda formulation Ashwagandhadi lehya as Aphrodisiac and in Treatment of Oligospermia


Affiliations
1 Pharmacognosy and Phytochemistry Department, Ramanbhai Patel College of Pharmacy, Charusat, At and Post – Changa, Dist. Anand, Gujarat, 388421, India
2 J.S. Ayurveda College, College Road, Nadiad, Gujarat, 387001, India
     

   Subscribe/Renew Journal


Ashwagandhadi lehya is traditionally used as aphrodisiac and spermatogenic. It is official in Ayurvedic Formulary of India. Root powder of Withania sominfera is incorporated as one of major ingredients in the formulation. The studies were aimed to evaluate Ashwagandhadi lehya, Clincially, as aphrodisiac and in treatment of Oligospermia. The duration of studies was 90 days and patients showed willingness to participate in studies were asked to submit blood and serum samples on 0, 45th and 90th day. Alteration in serum FSH, serum LH, serum testosterone as well as alteration in sperm concentration, % of normal sperms and % motile sperms in semen samples were selected as evaluation parameters to assess role of Ashwagandhadi lehya in treatment of oligospermia. Aphrodisiac potential of the formulation was evaluated by recording the responses of patients in a questioner, prepared on the basis of International Index of Erectile Function (IIEF- 5), included their experience in sexual desire, erection, penile rigidity, ejaculation and orgasm before and after treatment. The results showed that mean serum concentration of testosterone was increased by 8.31 % after 45 days of treatment and 16.53 % after 90 days of treatment, without concurrent alteration in serum FSH and serum LH concentration. Semen analysis showed that, after 90 days of treatment, mean sperm concentration in semen was increased by 200%, while % of normal sperms and % motile sperms were found to be increased by 11% and 59 %, respectively. The results of the studies showed, statistically significant improvement in sexual arousal, penile rigidity, orgasm and ejaculation, after treatment. As, testosterone concentration was increased in absence of increased LH release, it was concluded that formulation might act directly on testis and stimulated the expression of the proteins responsible for testosterone synthesis. It was also proposed that, increased in serum testosterone level might be responsible for aphrodisiac potential of Ashwagndhadi Lehya.

Keywords

Ashwagandhadi lehya, Vajikaran, Oligospermia, Spermatogenic, Aphrodisiac, Withania somifera.
Subscription Login to verify subscription
User
Notifications
Font Size


  • World Health Organization. Infecundity, infertility, and childlessness in developing countries. DHS Comparative Reports No 9. Calverton, Maryland, USA: ORC Macro and the World Health Organization; 2004.

  • Sharlip ID, Jarow JP, Belker AM, Lipshultz LI, Sigman M, Thomas AJ, Schlegel PN, Howards SS, Nehra A, Damewood MD, Overstreet JW, Sadovsky R. Best practice policies for male infertility. Fertility and Sterility. 2002; 77(5): 873-882

  • Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reproductive Biology and Endocrinology. 2015; 13 (37): 1-9.

  • Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence of decreasing quality of semen during past 50 years. British Medical Journal. 1992; 305(6854): 609-13.

  • Sciarra J. Infertility: an international health problem. International Journal of Gynaecology and Obstetrics. 1994; 46(1): 155–163.

  • DeRogatis LR, Burnett AL, 2008. The epidemiology of sexual dysfunctions. J. Sex. Med.,Vol. 5, 289–300.

  • Kaminetsky J. Epidemiology and pathophysiology of male sexual dysfunction. International. Journal of Impotence Research. 2008; 20: S3–S10.

  • Laumann EO, Paik A, Rosen RC, Page P. 1999. Sexual dysfunction in the United States. Journal of American Medical Association. 1999; 281(13): 537–545.

  • Meuleman EJH, van Lankveld, JJDM. Hypoactive sexual desire disorder: an underestimated condition in men. BJU International. 2005; 95(3): 291–296.

  • Mishra, B., 2006. Bhaishajyaratnavali. III, first ed., Chaukhambha Sanskrit Bhavan, India.

  • Anonymous. The Ayurvdic formulary of India, Vol-I, Ministry of Health and Family Welfare, Dept of AYUSH, New Delhi. 2003.

  • Mansi G, Deepa B, Pandey MM, Ojha SK, Sayyada K, Subha R, Rawat AKS. Standardization of Ashwagandhadilehya-an important ayurvedic formulation of Withaniasomnifera. Indian Journal of Traditional Knowledge. 2001; 10(4): 594–598.

  • Savitha HP, Shetty SK, Narayana P. An observational study on the efficacy of Ashwagandhadi lehya in healthy elders. International journal of Ayurvedic Medicine. 2016; 4(2): 211–217.

  • Tiwari M, Pandey A, Chundawat NS, Samagandi K. Clinical evaluation of rasayana effect of Ashwagandhadi lehya in apparently healthy elderly persons. Ancient Science of Life . 2016; 32(1-4): 26-37.

  • Anonymous. The Ayurvedic pharmacopoeia of India, Vol-III, Part-II. Ministry of Health and Family Welfare, Dept of AYUSH, New Delhi. 2000.

  • Trivedi MN, Khemani A, Vacchani UD, Shah CP, Santani DD. Pharmacognostic, phytochemical and microbiological studies of the plants Centella asiatica (Linn.) Urban and Withania somnifera (Linn) Dunal treasured and intelligence boost. Research Journal of Pharmacy and Technology. 2011; 4(11): 1707-1713.

  • Kirtikar, K.R and Basu, B.D. Indian Medicinal Plants, India. 1945.

  • Nadkarni, A.K. Indian Material Medica, Popular Prakashan. Delhi. 1976.

  • Mali PC, Chouhan PS, Chaudhary R. Evaluation of antifertility activity of Withaniasomnifera in male albino rats. Fertility and Sterility. 2008; 90 (S1): 18.

  • Ilayperuma I, Ratnasooriya WD, Weerasooriya TR. Effect of Withaniasomnifera ischolar_main extract on the sexual behavior of male rats. Asian Journal of Andrology. 2002; 4(4): 295–298.

  • Misra DS, Maiti R, Bera S, Das K, Ghosh D. Protective Effect of Composite Extract of Withaniasomnifera, Ocimum sanctum and Zingiberofficinale on swimming-induced reproductive endocrine dysfunctions in male rat. Iranian Journal of Pharmacology and Therapeutic Research. 2005; 405(1): 110–117.

  • Iuvone T, Esposito G, Capasso F, Izzo A. Induction of nitric oxide synthase expression by Withania somnifera in macrophages. Life sciences. 2003: 72(14): 1617-1625

  • Ambiye VR, Langade D, Dongre S, Aptikar P, Kulkarni M, Dongre A. Clinical evaluation of the spermatogenic activity of the ischolar_main extract of Ashwagandha (Withania somnifera) in oligospermic males: A pilot study. Available from: URL: https://www.hindawi.com/journals/ecam/2013/571420/

  • Ahmad MK, Mahdi AA, Shukla KK, Islam N, Rajender S, Madhukar D, Shankhwar SN, Ahmad S. Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertility and Sterility. 2010; 94 (3): 989–996.

  • Crosnoe LE, Grober E, Ohl D, Kim ED. Exogenous testosterone: a preventable cause of male infertility. Translational Andrology and Urology. 2013; 2(1): 106–113.

  • Harvey KV, Balon R. Clinical implications of antidepressant drug effects on sexual function. Annals of Clinical Psychiatry. 1995; 7(4): 189–201.

  • Kandeel FR, Koussa VKT, Swerdloff RS. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocrinology Review. 2001; 22(3): 342–388.

  • Madhukar D, Rajender S. Hormonal treatment of male infertility: promises and pitfalls. Journal of Andrology. 2008; 30(1): 95–112.

  • Ring JD, Lwin AA, Köhler TS. Current medical management of endocrine-related male infertility. Asian Journal of Andrology. 2016; 18(2): 357–63.

  • Stevenson RW, Solyom L. The aphrodisiac effect of fenfluramine: two case reports of a possible side effect to the use of fenfluramine in the treatment of bulimia. Journal of Clinical Psychopharmacology. 1990; 10(1): 69–71.

  • Cooper TG, Noonan E, Von Eckardstein S, Auger J, Baker HWG, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, Vogelsong KM, 2010. World Health Organization reference values for human semen characteristics. Human Reproduction Update. 2010; 16(3): 231–245.

  • Anonymous. WHO Laboratory manual for the examination and preservation of human semen, WHO, Switzerland. 2010.

  • Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997; 49(6), 822–830.

  • Virani NV, Chandola HM, Vyas SN, Jadeja DB. Clinical study on erectile dysfunction in diabetic and non-diabetic subjects and its management with Ficus religiosa linn. Ayu. 2010; 31(2): 272-279.

  • Carani C, Zini D, Baldini A, Casa L Della, Ghizzani A, Marrama P. Effects of androgen treatment in impotent men with normal and low levels of free testosterone. Archives of Sexual Behavior. 1990; 19 (3): 223–234.

  • Dufau ML, Winters CA, Hattori M, Aquilano D, Barañao JLS, Nozu K, Baukal A, Catt KJ. Hormonal regulation of androgen production by the Leydig cell. Journal of Steroidal Biochemistry. 1984; 20(1): 161–173.

  • Rommerts FFG, Brinkman AO. Modulation of steroidogenic activities in testis leydig cells. Molecular and Cellular Endocrinology. 1981; 21(1): 15–28.

  • Griswold MD. The central role of Sertoli cells in spermatogenesis. Seminal Cell Developmental Biology. 1988; 9(4): 411–416.

  • McLachlan RI, O’Donell L, Meachem SJ, Stanton PG, de Kretser DM, Partis K, Robertson DM. Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. Recent Progress in Hormonal Research. 2002; 57(1): 149–179.

  • Zinaman MJ, Brown CC, Selevan SG, Clegg ED. Semen quality and human fertility: a prospective study with healthy couples. Journal of Andrology. 2000; 21(1), 145-53.

  • Bosler JS, Davies KP, Neal-Perry GS. Peptides in seminal fluid and their role in infertility: a potential role for opiorphin inhibition of neutral endopeptidase activity as a clinically relevant modulator of sperm motility. Reproductive Science. 2010; 21 (11): 1334–1340.

  • Hull EM, Du J, Lorrain DS, Matuszewich L. Testosterone, preoptic dopamine, and copulation in male rats. Brain Research Bulletin. 1997; 44 (4): 327–333.

  • Liu YC, Sachs BD. Erectile function in male rats after lesions in the lateral paragigan to cellular nucleus. Neuroscience Letter. 1999; 262 (2), 203–206.

  • Carani C, Granata AR, Bancroft J, Marrama P. The effects of testosterone replacement on nocturnal penile tumescence and rigidity and erectile response to visual erotic stimuli in hypogonadal men. Psycho neuro endocrinology. 1995; 20 (7):743–53.

  • Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiology of Behavior. 2004; 83(2): 291–307.


Abstract Views: 240

PDF Views: 0




  • A Pilot Study on Evaluation of Standardized Ayurveda formulation Ashwagandhadi lehya as Aphrodisiac and in Treatment of Oligospermia

Abstract Views: 240  |  PDF Views: 0

Authors

Manan Raval
Pharmacognosy and Phytochemistry Department, Ramanbhai Patel College of Pharmacy, Charusat, At and Post – Changa, Dist. Anand, Gujarat, 388421, India
Manish Patel
J.S. Ayurveda College, College Road, Nadiad, Gujarat, 387001, India
Kanan Gamit
Pharmacognosy and Phytochemistry Department, Ramanbhai Patel College of Pharmacy, Charusat, At and Post – Changa, Dist. Anand, Gujarat, 388421, India
Kalapi Patel
J.S. Ayurveda College, College Road, Nadiad, Gujarat, 387001, India
S. N. Gupta
J.S. Ayurveda College, College Road, Nadiad, Gujarat, 387001, India

Abstract


Ashwagandhadi lehya is traditionally used as aphrodisiac and spermatogenic. It is official in Ayurvedic Formulary of India. Root powder of Withania sominfera is incorporated as one of major ingredients in the formulation. The studies were aimed to evaluate Ashwagandhadi lehya, Clincially, as aphrodisiac and in treatment of Oligospermia. The duration of studies was 90 days and patients showed willingness to participate in studies were asked to submit blood and serum samples on 0, 45th and 90th day. Alteration in serum FSH, serum LH, serum testosterone as well as alteration in sperm concentration, % of normal sperms and % motile sperms in semen samples were selected as evaluation parameters to assess role of Ashwagandhadi lehya in treatment of oligospermia. Aphrodisiac potential of the formulation was evaluated by recording the responses of patients in a questioner, prepared on the basis of International Index of Erectile Function (IIEF- 5), included their experience in sexual desire, erection, penile rigidity, ejaculation and orgasm before and after treatment. The results showed that mean serum concentration of testosterone was increased by 8.31 % after 45 days of treatment and 16.53 % after 90 days of treatment, without concurrent alteration in serum FSH and serum LH concentration. Semen analysis showed that, after 90 days of treatment, mean sperm concentration in semen was increased by 200%, while % of normal sperms and % motile sperms were found to be increased by 11% and 59 %, respectively. The results of the studies showed, statistically significant improvement in sexual arousal, penile rigidity, orgasm and ejaculation, after treatment. As, testosterone concentration was increased in absence of increased LH release, it was concluded that formulation might act directly on testis and stimulated the expression of the proteins responsible for testosterone synthesis. It was also proposed that, increased in serum testosterone level might be responsible for aphrodisiac potential of Ashwagndhadi Lehya.

Keywords


Ashwagandhadi lehya, Vajikaran, Oligospermia, Spermatogenic, Aphrodisiac, Withania somifera.

References